Why Renal Mass Balance Matters
A drug measured in urine has crossed several possible routes: it may have been filtered from plasma, secreted into the tubular lumen, or reabsorbed after entering the lumen. These processes are not interchangeable. In particular, the amount delivered to the kidney in plasma is not the amount filtered, and the amount filtered is not necessarily the amount ultimately excreted. A mass balance keeps these distinctions explicit.
The central accounting question is straightforward: over a specified time, what drug entered a defined compartment, what left it, and how much accumulated within it? Answering that question is useful both for steady-state calculations and for transient PBPK models, where compartment amounts may still be changing.
The Tubular and Whole-Kidney Balances
For a tubular-lumen control volume, filtration and secretion are inputs. Reabsorption and urinary outflow are outputs. Conservation of mass therefore gives the transient balance:
The urinary excretion rate can also be obtained from the measured urine flow and concentration:
where \(Q_{\rm urine}\) is urine volume per time and \(C_{\rm urine}\) is the parent-drug concentration in that urine. Their product has units of amount per time. A concentrated urine does not, by itself, imply a large excretion rate: urine flow must also be considered.
At steady state for the tubular lumen, its amount is constant, so \(dA_{\rm tub}/dt=0\). The balance then becomes:
This is a statement about rates of mass transfer, not about concentrations. It does not require filtration, secretion, or reabsorption to be individually constant over all time; it requires the balance to describe the time interval or steady condition being analyzed. If the lumen is filling or emptying, the steady-state equation alone does not apply.
In a simple filtration representation, \(J_{\rm filt}={\rm GFR}\,C_{p,u}\), where GFR is the glomerular filtration rate and \(C_{p,u}\) is the unbound drug concentration in plasma. This relation is used here as a bookkeeping input; the assumptions and physiological interpretation of unbound filtration require separate consideration. Secretion and reabsorption are net directional transfers across the tubular boundary, not synonyms for a particular transporter mechanism.
The whole kidney has a related but distinct balance. Let \(Q_{\rm RPF}\) denote renal plasma flow, \(C_{p,\rm in}\) and \(C_{p,\rm out}\) the drug concentrations in renal arterial and venous plasma, \(A_{\rm kidney}\) the total amount within the kidney, and \(J_{\rm met}\) the rate of irreversible renal metabolism of the parent drug. Under a steady-flow representation, conservation gives:
The two plasma-flow terms describe delivery to and return from the kidney. At steady state, the net difference between plasma delivery and venous return equals urinary excretion plus renal metabolism. During a transient, some of that difference can instead be accounted for by changing renal drug stores. Plasma delivery must not be added to filtration in the tubular equation: delivery is an organ-level input, whereas filtration is one route by which drug moves from plasma into the tubular lumen.
Worked Example: Steady-State Excretion With All Three Tubular Processes
Consider hypothetical steady-state values for a parent drug: GFR \(=0.120\ {\rm L/min}\), \(C_{p,u}=2.00\ {\rm mg/L}\), secretion \(J_{\rm sec}=0.100\ {\rm mg/min}\), and reabsorption \(J_{\rm reab}=0.0600\ {\rm mg/min}\). Urine flow is \(0.00100\ {\rm L/min}\). Assume no relevant tubular accumulation and that all rates refer to the same drug species and time condition.
First calculate the filtered rate using the stated filtration relation:
The steady-state tubular balance gives:
The urine concentration consistent with this excretion rate and the specified urine flow is:
The balance is internally consistent: the net input to the lumen is \(0.240+0.100-0.0600=0.280\ {\rm mg/min}\), matching urinary output. This calculation does not imply that every drug molecule follows all three routes; it accounts for the total rates across the defined boundary.
Connecting Plasma Delivery to Urinary Loss
The whole-kidney equation clarifies where the filtered and secreted drug ultimately come from: both are supported by drug delivered in plasma. But delivery is a broad input to the organ, not a direct measure of urinary output. Some delivered drug may return in renal venous plasma, some may be excreted, some may be metabolized, and some may temporarily accumulate in renal tissue or tubular fluid.
Worked Example: Steady-State Plasma Delivery and Renal Output
Suppose a hypothetical kidney has \(Q_{\rm RPF}=0.600\ {\rm L/min}\) and an arterial plasma concentration \(C_{p,\rm in}=5.00\ {\rm mg/L}\). Assume the tubular processes from the preceding calculation produce \(J_{\rm urine}=0.280\ {\rm mg/min}\). For this example, assume steady state, no renal metabolism, and equal plasma flow into and out of the kidney.
The rate of drug delivered in plasma is:
At steady state, the whole-kidney balance requires the plasma return rate to be \(3.00-0.280=2.72\ {\rm mg/min}\). The corresponding venous concentration is:
The difference between arterial and venous plasma delivery rates is \(3.00-2.72=0.280\ {\rm mg/min}\), equal to urinary excretion under the assumptions. It would be incorrect to set urinary excretion equal to the full \(3.00\ {\rm mg/min}\) delivered to the kidney: most of that drug returns in venous plasma in this example.
Transient Balance: Accumulation Changes the Answer
After a change in plasma concentration, urine flow, or renal transport, input and output rates may not balance immediately. The transient tubular equation shows how to account for this mismatch. Over an interval from \(t_0\) to \(t_1\), integration gives:
If the rates are constant over the interval, the amount accumulated is the net input rate multiplied by elapsed time. If the rates vary, the integral is needed; multiplying one instantaneous rate by the entire interval may give a misleading amount.
Worked Example: A Tubular Amount During a Transient
For a hypothetical 20-minute interval, assume the rates remain constant at \(J_{\rm filt}=0.300\ {\rm mg/min}\), \(J_{\rm sec}=0.120\ {\rm mg/min}\), and \(J_{\rm reab}=0.0800\ {\rm mg/min}\). The measured urinary excretion rate is \(J_{\rm urine}=0.240\ {\rm mg/min}\). These rates are assumed to describe the same drug species and the same interval.
The net rate of change in tubular amount is:
The tubular amount therefore increases over the interval by:
Thus urinary excretion is \(0.240\ {\rm mg/min}\), not the steady-state value \(0.340\ {\rm mg/min}\) that would equal filtration plus secretion minus reabsorption. The difference, \(0.100\ {\rm mg/min}\), is accounted for by accumulation in the lumen. If the initial tubular amount were \(1.50\ {\rm mg}\), the final amount would be \(3.50\ {\rm mg}\).
Assumptions, Diagnostics, and Alternatives
A mass balance is only as reliable as its boundary, species definition, and measurements. For the tubular equation, the assumed boundary must include the lumen segment or whole tubular space to which the fluxes refer. The rates must use compatible units and refer to the same interval. If parent drug is being balanced, a metabolite appearing in urine is not parent-drug excretion. If renal metabolism is material, include it in a whole-kidney parent-drug balance; it is not automatically a tubular-lumen output.
Useful diagnostic checks include:
- Check dimensions. Multiplying flow in volume per time by concentration in amount per volume must produce amount per time. All terms added or subtracted in one balance must have matching units.
- Check directions. Filtration and secretion enter the lumen in this convention; reabsorption and urinary outflow leave it. A negative calculated reabsorption rate may indicate inconsistent measurements, an omitted pathway, or a mismatch in definitions—not necessarily “negative reabsorption” as a physical process.
- Check accumulation. If the lumen is not at steady state, the difference between net entry and urinary outflow must be reflected in \(dA_{\rm tub}/dt\). For the whole kidney, also consider changing tissue or vascular amounts.
- Check measurement timing. A urine concentration paired with a flow measured over a different interval does not reliably specify the excretion rate for the balance being evaluated.
- Check species and pathways. Confirm whether reported urine measurements include only parent drug or also metabolites, and whether renal metabolism or other relevant losses need representation.
A common mistake is to write \(J_{\rm urine}=J_{\rm filt}+J_{\rm sec}\) because filtration and secretion are viewed as “renal elimination.” That omits reabsorption and assumes away transient storage. The correction is to begin with the control-volume balance, \(dA_{\rm tub}/dt=J_{\rm filt}+J_{\rm sec}-J_{\rm reab}-J_{\rm urine}\), and only then set the accumulation term to zero if steady state is justified.
A clearance-based summary can be useful when the question concerns an apparent rate relative to a plasma concentration, but it does not by itself separate filtration, secretion, and reabsorption. A compartmental PBPK model instead represents drug amounts and transfers over time, allowing transient accumulation to be simulated. The mass-balance equations remain the accounting constraints in either approach; the more detailed model specifies how its fluxes vary with concentrations and physiology. These equations alone do not identify the individual pathways from a single urine measurement, nor do they specify transporter kinetics or nephron-segment mechanisms.
The key practical limitation is that aggregate rates can conceal where along the nephron a transfer occurred and how it changed with concentration or time. The balance can reveal a mismatch or quantify a net rate when the other terms are known, but it cannot manufacture information that was not measured or modeled. When a calculation fails to close, revisit the control volume, time scale, drug species, and omitted storage or metabolic terms before assigning a biological mechanism.
Check Your Understanding
Answer each question using the stated assumptions; brief solutions follow the questions.
- At steady state, \(J_{\rm filt}=0.180\ {\rm mg/min}\), \(J_{\rm sec}=0.0700\ {\rm mg/min}\), and \(J_{\rm reab}=0.0300\ {\rm mg/min}\). What is \(J_{\rm urine}\)?
- Urine flow is \(0.00200\ {\rm L/min}\) and urine concentration is \(75.0\ {\rm mg/L}\). What is the urinary excretion rate?
- During a transient, the sum of filtration and secretion is \(0.500\ {\rm mg/min}\), reabsorption is \(0.100\ {\rm mg/min}\), and urinary outflow is \(0.250\ {\rm mg/min}\). Is tubular drug amount increasing or decreasing, and at what rate?
- At steady state, plasma delivery is \(4.00\ {\rm mg/min}\), urinary excretion is \(0.300\ {\rm mg/min}\), and renal metabolism is \(0.100\ {\rm mg/min}\). What is the rate of drug return in renal venous plasma?
Solutions. (1) \(J_{\rm urine}=0.180+0.0700-0.0300=0.220\ {\rm mg/min}\). (2) \(J_{\rm urine}=Q_{\rm urine}C_{\rm urine}=(0.00200)(75.0)=0.150\ {\rm mg/min}\). (3) The rate of change is \(0.500-0.100-0.250=0.150\ {\rm mg/min}\), so tubular amount is increasing. (4) At steady state with no other terms, venous return is \(4.00-0.300-0.100=3.60\ {\rm mg/min}\).